相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR
Guntram Schernthaner
WIENER MEDIZINISCHE WOCHENSCHRIFT (2010)
Endogenous cardiac natriuretic peptides protect the heart in a mouse model of dilated cardiomyopathy and sudden death
Shinji Yasuno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1 alpha delivery and endogenous cytokine signaling
Tiemin Zhao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
Tanika N. Kelly et al.
ANNALS OF INTERNAL MEDICINE (2009)
B-Type Natriuretic Peptide-Induced Cardioprotection against Reperfusion Is Associated with Attenuation of Mitochondrial Permeability Transition
Yiguo Sun et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function
Ketul R. Chaudhary et al.
CARDIOVASCULAR RESEARCH (2009)
Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
Marc-Michael Zaruba et al.
CELL STEM CELL (2009)
Importance of the SDF-1:CXCR4 Axis in Myocardial Repair
Marc S. Penn
CIRCULATION RESEARCH (2009)
Effect of saxagliptin monotherapy in treatment-naive patients with type 2 diabetes
J. Rosenstock et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
Ralph A. DeFronzo et al.
DIABETES CARE (2009)
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
M. Jadzinsky et al.
DIABETES OBESITY & METABOLISM (2009)
Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial
A. R. Chacra et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone
Priscilla Hollander et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy
Jolanta Gutkowska et al.
JOURNAL OF PHYSIOLOGY-LONDON (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Premature Release of Data from Clinical Trials of Ezetimibe
Robert M. Califf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William Duckworth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Current Unmet Need in Type 2 Diabetes Mellitus: Addressing Glycemia and Cardiovascular Disease
Philip Levy
POSTGRADUATE MEDICINE (2009)
Endothelial Nitric Oxide Synthase Promotes Bone Marrow Stromal Cell Migration to the Ischemic Myocardium via Upregulation of Stromal Cell-Derived Factor-1 alpha
Na Li et al.
STEM CELLS (2009)
Pretreatment with B-type Natriuretic Peptide Protects the Heart From Ischemia-Reperfusion Injury by Inhibiting Myocardial Apoptosis
Bing Wu et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Stromal cell-derived factor-1α is cardioprotective after myocardial infarction
Ankur Saxena et al.
CIRCULATION (2008)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
Genetic enhancement of stem cell engraftment, survival, and efficacy
Marc S. Penn et al.
CIRCULATION RESEARCH (2008)
Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes
J. Rosenstock et al.
DIABETES OBESITY & METABOLISM (2008)
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Timothy B. Campbell et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Benefits and risks of tight glucose control in critically ill adults - A meta-analysis
Renda Soylemez Wiener et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
UKPDS and the legacy effect
John Chalmers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Formation of large coronary arteries by cardiac progenitor cells
Jochen Tillmanns et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An analysis of eight 95 per cent confidence intervals for a ratio of Poisson parameters when events are rare
Lawrence Barker et al.
STATISTICS IN MEDICINE (2008)
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis
Debora Williams-Herman et al.
BMC Endocrine Disorders (2008)
Adenovirus-mediated stromal cell-derived- factor-1 gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis
J. Tang et al.
Interactive Cardiovascular and Thoracic Surgery (2008)
Stromal cell-derived factor-1α improves infarcted heart function through angiogenesis in mice
Takashi Sasaki et al.
PEDIATRICS INTERNATIONAL (2007)
Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction
Vincent F. M. Segers et al.
CIRCULATION (2007)
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction
Ming Zhang et al.
FASEB JOURNAL (2007)
Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway
Amal K. Bose et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Diprotin A infusion into nonobese diabetic/severe combined immunodeficiency mice markedly enhances engraftment of human mobilized CD34+ peripheral blood cells
Toshinao Kawai et al.
STEM CELLS AND DEVELOPMENT (2007)
Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium
I. Elmadbouh et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography
Erdal Cavusoglu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population
Carolyn S. P. Lam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation
Guido Boerrigter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis
Hal E. Broxmeyer et al.
HEMATOPOIETIC STEM CELLS VI (2007)
SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo
Samuel Unzek et al.
CELL TRANSPLANTATION (2007)
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
George G. Sokos et al.
JOURNAL OF CARDIAC FAILURE (2006)
G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells
Kent W. Christopherson et al.
EXPERIMENTAL HEMATOLOGY (2006)
Dilpeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form
I Brandt et al.
CLINICAL CHEMISTRY (2006)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
DM Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
RANTES gene polymorphisms redict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients
CA Böger et al.
ATHEROSCLEROSIS (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1
MH Yamani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5
JK Kim et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines
LA Nikolaidis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
LA Nikolaidis et al.
CIRCULATION (2004)
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
LA Nikolaidis et al.
CIRCULATION (2004)
Modulation of hematopoietic stem cell homing and engraftment by CD26
KW Christopherson et al.
SCIENCE (2004)
Stromal cell-derived factor-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury
JD Abbott et al.
CIRCULATION (2004)
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
WC Liles et al.
BLOOD (2003)
Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy
AT Askari et al.
LANCET (2003)
Surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells
KW Christopherson et al.
BLOOD (2003)
Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family
AM Lambeir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
